biosystemix.com
About company
Biosystemix (privately held, founded in 2003) aims to become the leading provider of personalized medicine solutions that will transform the clinical and economic practice of medicine. Biosystemix generates groundbreaking products for medical decision making and therapeutics through: (1) Partnerships with leading clinical institutions for the discovery of the biomolecular profiles predictive of disease and therapeutic outcomes; (2) computational and information science technologies for the modeling and prediction of clinical treatments and outcomes. Biosystemix creates high medico-economic value through products that (i) lead to more effective treatments, (ii) reduce ineffective treatments, and (iii) reduce the costs of patient care.
